-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HEEor5O+6x9uouuCBln/Qnct0G79fvweuScDhVZm5HtwVO7vW4uWTvwl84pVf5SJ mPOB613ZeK8oYtCvK5XtFw== 0001104659-10-007585.txt : 20100217 0001104659-10-007585.hdr.sgml : 20100217 20100217151843 ACCESSION NUMBER: 0001104659-10-007585 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20100217 DATE AS OF CHANGE: 20100217 GROUP MEMBERS: GREENSTAR NORTH AMERICA HOLDINGS, INC. GROUP MEMBERS: NTR US BIOSYSTEMS HOLDINGS LIMITED SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Green Plains Renewable Energy, Inc. CENTRAL INDEX KEY: 0001309402 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 841652107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81560 FILM NUMBER: 10612547 BUSINESS ADDRESS: STREET 1: 9420 UNDERWOOD AVE., STE. 100 CITY: OMAHA STATE: NE ZIP: 68114 BUSINESS PHONE: 402-884-8700 MAIL ADDRESS: STREET 1: 9420 UNDERWOOD AVE., STE. 100 CITY: OMAHA STATE: NE ZIP: 68114 FORMER COMPANY: FORMER CONFORMED NAME: GREEN PLAINS RENEWABLE ENERGY, INC. DATE OF NAME CHANGE: 20060314 FORMER COMPANY: FORMER CONFORMED NAME: Green Plains Renewable Energy, Inc. DATE OF NAME CHANGE: 20041123 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NTR plc CENTRAL INDEX KEY: 0001447763 IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: BURTON COURT, BURTON HALL DRIVE STREET 2: SANDYFORD CITY: DUBLIN STATE: L2 ZIP: 18 BUSINESS PHONE: 353-0-1-206-3700 MAIL ADDRESS: STREET 1: BURTON COURT, BURTON HALL DRIVE STREET 2: SANDYFORD CITY: DUBLIN STATE: L2 ZIP: 18 SC 13D/A 1 a10-4030_1sc13da.htm SC 13D/A

 

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

 

Washington, D.C. 20549

 

 

 

 

SCHEDULE 13D

 

 

 

 

Under the Securities Exchange Act of 1934
(Amendment No. 2)*

 

Green Plains Renewable Energy, Inc.

(Name of Issuer)

 

Common Stock, $.001 Par Value

(Title of Class of Securities)

 

393222104

(CUSIP Number)

 

David T. Quinby, Esq.

Rebecca B. Sandberg, Esq.

Stoel Rives LLP

33 South Sixth Street, Suite 4200

Minneapolis, Minnesota 55402

(612) 373-8800

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

February 12, 2010

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

Persons who respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB control number.

 



 

CUSIP No.   393222104

 

 

1.

Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
NTR plc
No IRS Identification Number

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

If any of the shares beneficially owned by a reporting person are held as a member of a group and the membership is expressly affirmed, please check. o

 

 

(b)

If the reporting person disclaims membership in a group or describes a relationship with other person but does not affirm the existence of a group, please check.  (Unless it is a joint filing pursuant to Rule 13d-1(k)(1), in which case, it may not be necessary to check this 2(b)). x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
Not Applicable

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
Ireland

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power

 

8.

Shared Voting Power
11,227,653

 

9.

Sole Dispositive Power

 

10.

Shared Dispositive Power
11,227,653

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
11,227,653

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   x*

 

 

13.

Percent of Class Represented by Amount in Row (11)
45.0% (Based upon 24,964,389 shares outstanding as of November 2, 2009, as reported in the Form 10-Q filed with the SEC on or about November 10, 2009)

 

 

14.

Type of Reporting Person (See Instructions)
CO – Corporation

 


* As a result of the Shareholders’ Agreement described in Item 6 of the initial Schedule 13D, the Reporting Persons may be deemed to be the beneficial owners of shares of the Issuer’s common stock beneficially owned by Wilon Holdings S.A. and Wayne Hoovestol.  Based on the most recent information filed with the SEC, as further described in Item 5 of this Amended Schedule 13D, Wilon Holdings S.A. beneficially owns 2,070,716 shares of the Issuer’s common stock, representing approximately 8.3% of the issued and outstanding common stock of the Issuer.  Based on the most recent information filed with the SEC, Wayne Hoovestol beneficially owns 954,592 shares of the Issuer’s common stock, representing approximately 3.8% of issued and outstanding common stock of the Issuer.  Each Reporting Person expressly disclaims beneficial ownership of the shares beneficially owned by Wilon Holdings S.A. and Wayne Hoovestol, except to the extent of any pecuniary interest they may have therein.

 

2



 

CUSIP No.   393222104

 

 

1.

Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
NTR US Biosystems Holdings Limited
No IRS Identification Number

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

If any of the shares beneficially owned by a reporting person are held as a member of a group and the membership is expressly affirmed, please check. o

 

 

(b)

If the reporting person disclaims membership in a group or describes a relationship with other person but does not affirm the existence of a group, please check.  (Unless it is a joint filing pursuant to Rule 13d-1(k)(1), in which case, it may not be necessary to check this 2(b)). x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
Not Applicable

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
Ireland

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power

 

8.

Shared Voting Power
5,234,000

 

9.

Sole Dispositive Power

 

10.

Shared Dispositive Power
5,234,000

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
11,227,653

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   x*

 

 

13.

Percent of Class Represented by Amount in Row (11)
45.0% (Based upon 24,964,389 shares outstanding as of November 2, 2009, as reported in the Form 10-Q filed with the SEC on or about November 10, 2009)

 

 

14.

Type of Reporting Person (See Instructions)
CO – Corporation

 


* As a result of the Shareholders’ Agreement described in Item 6 of the initial Schedule 13D, the Reporting Persons may be deemed to be the beneficial owners of shares of the Issuer’s common stock beneficially owned by Wilon Holdings S.A. and Wayne Hoovestol.  Based on the most recent information filed with the SEC, as further described in Item 5 of this Amended Schedule 13D, Wilon Holdings S.A. beneficially owns 2,070,716 shares of the Issuer’s common stock, representing approximately 8.3% of the issued and outstanding common stock of the Issuer.  Based on the most recent information filed with the SEC, Wayne Hoovestol beneficially owns 954,592 shares of the Issuer’s common stock, representing approximately 3.8% of issued and outstanding common stock of the Issuer.  Each Reporting Person expressly disclaims beneficial ownership of the shares beneficially owned by Wilon Holdings S.A. and Wayne Hoovestol, except to the extent of any pecuniary interest they may have therein.

 

3



 

CUSIP No.   393222104

 

 

1.

Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Greenstar North America Holdings, Inc.
IRS Identification Number:  20-8232960

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

If any of the shares beneficially owned by a reporting person are held as a member of a group and the membership is expressly affirmed, please check. o

 

 

(b)

If the reporting person disclaims membership in a group or describes a relationship with other person but does not affirm the existence of a group, please check.  (Unless it is a joint filing pursuant to Rule 13d-1(k)(1), in which case, it may not be necessary to check this 2(b)). x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
Not Applicable

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
Delaware

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power

 

8.

Shared Voting Power
5,993,653

 

9.

Sole Dispositive Power

 

10.

Shared Dispositive Power
5,993,653

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
11,227,653

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   x*

 

 

13.

Percent of Class Represented by Amount in Row (11)
45.0% (Based upon 24,964,389 shares outstanding as of November 2, 2009, as reported in the Form 10-Q filed with the SEC on or about November 10, 2009)

 

 

14.

Type of Reporting Person (See Instructions)
CO – Corporation

 


* As a result of the Shareholders’ Agreement described in Item 6 of the initial Schedule 13D, the Reporting Persons may be deemed to be the beneficial owners of shares of the Issuer’s common stock beneficially owned by Wilon Holdings S.A. and Wayne Hoovestol.  Based on the most recent information filed with the SEC, as further described in Item 5 of this Amended Schedule 13D, Wilon Holdings S.A. beneficially owns 2,070,716 shares of the Issuer’s common stock, representing approximately 8.3% of the issued and outstanding common stock of the Issuer.  Based on the most recent information filed with the SEC, Wayne Hoovestol beneficially owns 954,592 shares of the Issuer’s common stock, representing approximately 3.8% of issued and outstanding common stock of the Issuer.  Each Reporting Person expressly disclaims beneficial ownership of the shares beneficially owned by Wilon Holdings S.A. and Wayne Hoovestol, except to the extent of any pecuniary interest they may have therein.

 

4



 

This Amendment No. 2 to Schedule 13D/A (this “Schedule 13D/A”) is being filed to amend and supplement (i) the initial Schedule 13D filed by the Reporting Persons with the Securities and Exchange Commission (“SEC”) on October 27, 2008 (the “initial Schedule 13D”) and (ii) Amendment No. 1 to Schedule 13D/A filed by the Reporting Persons with the SEC on November 4, 2008 (“Amendment No. 1”).  Except as specifically amended by this Schedule 13D/A, the initial Schedule 13D and Amendment No. 1 remain unchanged.  Capitalized terms used and not otherwise defined in this Schedule 13D/A have the meanings given them in the initial Schedule 13D and Amendment No. 1, as applicable.

 

Item 2.  Identity and Background

 

This Statement is being filed on behalf of each of the following reporting persons (collectively, the “Reporting Persons”):

 

NTR plc, a public limited company registered in Ireland (“NTR”), which has its principal office address at Burton Court, Burton Hall Drive, Sandyford, Dublin 18, Ireland. NTR is a leading international developer and operator of renewable energy and sustainable waste management projects.

 

NTR US Biosystems Holdings Limited, a company organized under the laws of Ireland (“Biosystems”), which has its principal office address at Burton Court, Burton Hall Drive, Sandyford, Dublin 18, Ireland. Biosystems is a holding company and a wholly owned subsidiary of NTR.

 

Greenstar North America Holdings, Inc., a Delaware corporation (“Greenstar”), which has its principal office address at 3411 Richmond Avenue, Suite 700 Houston TX 77046.  Greenstar is a holding company and a wholly owned subsidiary of NTR.

 

The Joint Filing Agreement and Amendment No. 1 thereto, among the Reporting Persons to file this Statement on Schedule 13D/A jointly in accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934 are filed herewith as Exhibits K and L. Certain information contained in this Statement relates to share ownership of persons other than the Reporting Persons. The Reporting Persons expressly disclaim any liability for any such information provided in this Statement that does not expressly pertain to a Reporting Person.

 

During the last five years, none of the Reporting Persons has been (a) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) nor (b) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which it was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws finding any violation with respect to such laws.

 

Item 3.  Source and Amount of Funds or Other Consideration

 

Pursuant to an Assignment and Assumption Agreement dated February 12, 2010, Biosystems transferred and assigned a total of 5,993,653 shares of the Issuer’s common stock (the “Shares”) to its affiliate, Greenstar, and Biosystems received as consideration an equivalent number of shares of Greenstar’s common stock.  No cash was exchanged between the parties in connection with the transfer.  Biosystems and Greenstar are each wholly owned subsidiaries of NTR, which remains the indirect beneficial owner of all such Shares.

 

Item 5.  Interest in Securities of the Issuer

 

As described in Item 3, pursuant to an Assignment and Assumption Agreement dated February 12, 2010, Biosystems transferred and assigned a total of 5,993,653 Shares to its affiliate, Greenstar, and Biosystems received as consideration an equivalent number of shares of Greenstar’s common stock.  Biosystems and Greenstar are each wholly owned subsidiaries of NTR, and following the transaction NTR remains the indirect beneficial owner of such Shares.  Following the transfer of shares from Biosystems to Greenstar, the Reporting Persons continue to beneficially own 11,227,653 shares of Issuer’s common stock, or approximately 45.0% of the issued and outstanding common stock of the Issuer.

 

Additionally, as a result of the Shareholders’ Agreement by and among the Issuer, Biosystems (formerly known as Bioverda International Holdings Ltd.), Bioverda US Holdings LLC, Wilon Holdings S.A. and Wayne Hoovestol, the

 

5



 

Reporting Persons may also be deemed to be the beneficial owners of shares of the Issuer’s common stock beneficially owned by Wilon and Mr. Hoovestol.  Based on the most recent information filed with the SEC, Wilon beneficially owns 2,070,716 shares of the Issuer’s common stock, representing approximately 8.3% of the issued and outstanding common stock of the Issuer, and Mr. Hoovestol beneficially owns 954,592 shares of the Issuer’s common stock, representing approximately 3.8% of issued and outstanding common stock of the Issuer.  Each Reporting Person expressly disclaims beneficial ownership of the shares beneficially owned by Wilon and Mr. Hoovestol, except to the extent of any pecuniary interest they may have therein.

 

Item 7.  Material to Be Filed as Exhibits

 

Exhibits (a) through (k) listed below were filed as exhibits to the initial Schedule 13D filed with the SEC on October 27, 2008 and are incorporated by reference in this Schedule 13D/A by reference thereto.  Exhibits (l) and (m) are filed herewith.

 

(a)

Agreement and Plan of Merger dated May 7, 2008, by and among Green Plains Renewable Energy, Inc., Green Plains Merger Sub, Inc., and VBV LLC (incorporated by reference to Exhibit (a) to the Reporting Persons’ initial Schedule 13D filed October 27, 2008)

(b)

Stock Purchase Agreement dated May 7, 2008 by and among Green Plains Renewable Energy, Inc., Bioverda International Holdings Limited and Bioverda US Holdings LLC (incorporated by reference to Exhibit (b) to the Reporting Persons’ initial Schedule 13D filed October 27, 2008)

(c)

Shareholders’ Agreement dated October 15, 2008 by and among Green Plains Renewable Energy, Inc., Bioverda International Holdings Limited, Bioverda US Holdings LLC and Wayne Hoovestol (incorporated by reference to Exhibit (c) to the Reporting Persons’ initial Schedule 13D filed October 27, 2008)

(d)

Lock-Up and Voting Agreement dated May 7, 2008 by and among Green Plains Renewable Energy, Inc., Bioverda International Holdings Limited and Bioverda US Holdings LLC (incorporated by reference to Exhibit (d) to the Reporting Persons’ initial Schedule 13D filed October 27, 2008)

(e)

Put and Call Agreement (VBV) dated April 1, 2008 by and among Bioverda International, Bioverda US Holdings LLC and Wilon Holdings S.A. (incorporated by reference to Exhibit (e) to the Reporting Persons’ initial Schedule 13D filed October 27, 2008)

(f)

Notice of exercise of Put Option (VBV) dated October 1, 2008, as amended effective October 15, 2008 (incorporated by reference to Exhibit (f) to the Reporting Persons’ initial Schedule 13D filed October 27, 2008)

(g)

Put and Call Agreement (GPRE) dated April 1, 2008 by and among Bioverda International, Bioverda US Holdings LLC and Wilon Holdings S.A. (incorporated by reference to Exhibit (g) to the Reporting Persons’ initial Schedule 13D filed October 27, 2008)

(h)

Notice of exercise of Put Option (GPRE) dated October 1, 2008, as amended effective October 15, 2008 (incorporated by reference to Exhibit (h) to the Reporting Persons’ initial Schedule 13D filed October 27, 2008)

(i)

Lock-Up and Voting Agreement dated May 7, 2008 by and among Green Plains Renewable Energy, Inc. and Wilon Holdings S.A. (incorporated by reference to Exhibit (i) to the Reporting Persons’ initial Schedule 13D filed October 27, 2008)

(j)

Lock-Up and Voting Agreement dated May 7, 2008 by and between Wayne Hoovestol and VBV LLC (incorporated by reference to Exhibit (j) to the Reporting Persons’ initial Schedule 13D filed October 27, 2008)

(k)

Joint Filing Agreement, among the Reporting Persons (incorporated by reference to Exhibit (k) to the Reporting Persons’ initial Schedule 13D filed October 27, 2008)

(l)

Amendment No. 1 to Joint Filing Agreement, among the Reporting Persons

(m)

Assignment and Assumption Agreement dated February 12, 2010 between NTR US Biosystems Holdings Limited and Greenstar North American Holdings Inc.

 

6



 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

February 17, 2010

 

Date

 


/s/ Jeremy Nel

 

Signature

 


Group Executive: Commercial & Legal

 

Name/Title

 

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement: provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

 

 

 

ATTENTION:

 

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001)

 

7


EX-99.(L) 2 a10-4030_1ex99dl.htm EX-99.(L)

Exhibit 99.(l)

 

AMENDMENT NO. 1 TO JOINT FILING AGREEMENT

 

This Amendment No. 1 to Joint Filing Agreement is entered into as of this 16th day of February, 2010 (this “Amendment”), among NTR plc (“NTR”), NTR US Biosystems Holdings Limited, formerly known as Bioverda International Holdings Limited (“Biosystems”), and Greenstar North America Holdings, Inc. (“Greenstar” and, together with NTR and Biosystems the “Reporting Persons”).  This Amendment amends the Joint Filing Agreement (the “Joint Filing Agreement”) dated as of October 27, 2008, among NTR, Biosystems, and Bioverda US Holdings LLC (“Bioverda”).

 

WHEREAS, Bioverda is no longer an owner of any shares of common stock, par value $.001 per share (“Common Stock”), of Green Plains Renewable Energy, Inc., an Iowa corporation (“GPRE”); and

 

WHEREAS, Greenstar has become an owner of shares of Common Stock of GPRE; and

 

WHEREAS, the Reporting Persons desire to amend the Joint Filing Agreement to add Greenstar as a party to the Joint Filing Agreement and to remove Bioverda as a party to the Joint Filing Agreement.

 

NOW, THEREFORE, in consideration of the foregoing, the Reporting Persons hereto agree as follows:

 

1.  Inclusion in Joint Filing Agreement.  The Joint Filing Agreement is hereby amended to provide that Greenstar is a party to the Joint Filing Agreement and is subject to all of the terms and conditions contained therein.

 

2.  Withdrawal from Joint Filing Agreement. The Joint Filing Agreement is hereby amended to provide that Bioverda is no longer a party to the Joint Filing Agreement.

 

3.  Joint Filing Agreement.  Except as amended hereby, the Joint Filing Agreement shall remain in full force and effect and is hereby ratified, confirmed and approved in all respects.

 

The Joint Filing Agreement may be executed in any number of counterparts all of which together shall constitute one and the same instrument.

 

[remainder of page intentionally left blank]

 



 

IN WITNESS WHEREOF, the undersigned hereby execute this Amendment as of this 16th day of February, 2010.

 

NTR plc

 

By:

/s/ Eamon Bolger

 

Name:

Eamon Bolger

 

Title:

Company Secretary

 

 

 

 

 

 

 

NTR US BIOSYSTEMS HOLDINGS LIMITED

 

 

 

 

 

 

By:

/s/ Rosheen McGuckian

 

Name:

Rosheen McGuckian

 

Title:

Director

 

 

 

 

 

 

 

GREENSTAR NORTH AMERICA HOLDINGS, INC.

 

 

 

 

 

 

By:

/s/ Michael Wynne

 

Name:

Michael Wynne

 

Title:

Director

 

 


EX-99.M 3 a10-4030_1ex99dm.htm EX-99.M

Exhibit 99.(m)

 

Assignment and Assumption Agreement

 

This Assignment and Assumption Agreement (this “Assignment”) is made and entered into as of February 12, 2010, by and between NTR US Biosystems Holdings Limited (f/k/a Bioverda International Holdings Ltd.) (the “Assignor”) and Greenstar North America Holdings Inc., a Delaware corporation (the “Assignee”).

 

Recitals

 

A.            Effective as of the date hereof, Assignor transferred to Assignee 5,993,653 shares of common stock (the “Shares”) of Green Plains Renewable Energy, Inc., an Iowa corporation (the “Company”).

 

B.            Assignor is a party to that certain Shareholders’ Agreement, dated May 7, 2008, by and among the Company, Bioverda US Holdings LLC, Wilon Holdings S.A., Assignor, and Wayne Hoovestol (the “Shareholders’ Agreement”).

 

C.            In connection with the above-referenced transfer of Shares, Assignor desires to assign all of Assignor’s rights, and delegate all of its obligations, under the Shareholders’ Agreement to Assignee, and Assignee is willing to accept and assume such rights and obligations and agree to be bound by the terms and conditions of the Shareholders’ Agreement.

 

Agreement

 

1.             Assignor hereby assigns all of Assignor’s rights and interest in and to the Shareholders’ Agreement, and delegates all of Assignor’s duties and obligations under the Shareholders’ Agreement, to Assignee.  Assignee hereby accepts the foregoing assignment and delegation and assumes and promises to perform all of the obligations of Assignor under the Shareholders’ Agreement arising as of and after the date hereof.

 

2.             Assignee hereby agrees to be bound by the terms and conditions of the Shareholders’ Agreement.

 

3.             This Assignment shall inure to the benefit of and shall be binding upon each of the parties hereto and their successors and assigns.  The parties shall execute and deliver such further and additional instruments, agreements and other documents, and take such other actions, as may be necessary to carry out the provisions of this Assignment.  This Assignment shall be governed by the laws of the State of Delaware

 



 

IN WITNESS WHEREOF, the parties hereto have duly executed this Assignment as of the day and year first set forth above.

 

 

ASSIGNOR

 

ASSIGNEE

 

 

 

NTR US Biosystems Holdings Limited

 

Greenstar North America Holdings Inc.

(f/k/a Bioverda International Holdings Ltd.)

 

 

 

 

 

 

 

 

/s/ Rosheen McGuckian

 

/s/ James Timothy Barry

 

 

 

By: Rosheen McGuckian

 

By:  James Timothy Barry

 

 

 

Its: Director

 

Its:  Director

 


-----END PRIVACY-ENHANCED MESSAGE-----